Long-lived proteins and DNA as candidate predictive biomarkers for tissue associated diseases
View abstract on PubMed
Summary
This summary is machine-generated.This study maps long-lived proteins (LLPs) in mice, revealing tissue-specific patterns. These proteins, accumulating damage over time, may serve as biomarkers for aging and related diseases.
Area Of Science
- Biochemistry
- Proteomics
- Aging Research
Background
- Protein turnover is vital for maintaining cellular health (proteostasis).
- Long-lived proteins (LLPs) accumulate damage over time, risking functional decline.
- Understanding LLP dynamics is crucial for aging and disease research.
Purpose Of The Study
- To identify and map long-lived proteins (LLPs) across various mouse tissues and plasma.
- To investigate the relationship between LLP accumulation, DNA renewal, and age-related pathologies.
- To explore the potential of LLPs as biomarkers for aging and associated diseases.
Main Methods
- Employed in vivo stable isotope labeling in mice from birth to adulthood (day 89).
- Conducted quantitative proteomics analysis on ten tissues and plasma samples.
- Quantified deoxynucleosides to assess cellular DNA renewal rates.
Main Results
- Identified 2113 long-lived proteins (LLPs), with both widespread and tissue-specific distributions.
- Detected a significant proportion of LLPs in plasma, suggesting links to cardiovascular diseases.
- Found correlations between brain LLPs and DNA renewal rates, implicating neurodegenerative disease pathways.
- Generated comprehensive, tissue-specific maps of mouse LLPs.
Conclusions
- Tissue-specific LLP maps highlight proteins vulnerable to damage due to low renewal rates.
- Plasma-derived LLPs show promise as biomarkers for aging and age-related cardiovascular diseases.
- Brain LLPs may be associated with neurodegenerative conditions, warranting further investigation.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...

